(Q33889550)

29 July 2017

1 reference

title

Update on Haemophilus influenzae serotype b and meningococcal vaccines (English)

1 reference

29 July 2017

main subject

meningococcal vaccine

1 reference

based on heuristic

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

Rosenstein NE

1

1 reference

29 July 2017

Perkins BA

series ordinal

2

1 reference

29 July 2017

language of work or name

1 reference

1 April 2000

1 reference

Pediatric Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

47

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

337-52, vi

1 reference

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Immunoprophylaxis of meningococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Epidemiology of Haemophilus influenzae type b infections in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Complications and sequelae of meningococcalinfections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Vaccines for prevention of meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Human immunity to the meningococcus. II. Development of natural immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Human immunity to the meningococcus. I. The role of humoral antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Meningococcal Carriage in a Population of "Normal" Families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Meningococcal molecular mimicry and the search for an ideal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Risk of meningococcal infection in college students.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Meningococcal carriage, meningococcal disease and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Serogroup C meningococcal outbreaks in the United States. An emerging threat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Group A meningococcal carriage in travelers returning from Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Efficacy of meningococcal vaccine and barriers to vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Bacterial meningitis in the United States in 1995. Active Surveillance Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

The epidemiology and prevention of disease caused by Haemophilus influenzae type b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: attachment and entry into columnar epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Effect of smoking on meningococcal carriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Capsule switching of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Emergency vaccination against epidemic meningitis in Ghana: Implications for the control of meningococcal disease in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

A Simultaneous Outbreak of Meningococcal and Influenza Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970210-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70210-8

1 reference

29 July 2017

1 reference